SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-21-154105
Filing Date
2021-05-07
Accepted
2021-05-07 07:53:22
Documents
80
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q d144291d10q.htm   iXBRL 10-Q 1522184
2 EX-31.1 d144291dex311.htm EX-31.1 10263
3 EX-31.2 d144291dex312.htm EX-31.2 10316
4 EX-32 d144291dex32.htm EX-32 4503
10 GRAPHIC g144291g0130014651346.jpg GRAPHIC 5673
  Complete submission text file 0001193125-21-154105.txt   7377627

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA vivo-20210331.xsd EX-101.SCH 58717
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vivo-20210331_cal.xml EX-101.CAL 52413
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vivo-20210331_def.xml EX-101.DEF 300627
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE vivo-20210331_lab.xml EX-101.LAB 432327
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vivo-20210331_pre.xml EX-101.PRE 391938
11 EXTRACTED XBRL INSTANCE DOCUMENT d144291d10q_htm.xml XML 1446684
Mailing Address 3471 RIVER HILLS DRIVE CINCINNATI OH 45244
Business Address 3471 RIVER HILLS DR CINCINNATI OH 45244 5132713700
MERIDIAN BIOSCIENCE INC (Filer) CIK: 0000794172 (see all company filings)

IRS No.: 310888197 | State of Incorp.: OH | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 000-14902 | Film No.: 21900307
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Office of Life Sciences